Trials / Completed
CompletedNCT01342055
Pharmacokinetics and Safety Study of Apetrol ES in Healthy Male Volunteers
Phase I Study of Apetrol ES and Megace® in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 38 (actual)
- Sponsor
- LG Life Sciences · Industry
- Sex
- Male
- Age
- 20 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
A Randomized, Open Label, Single dose, Cross-over, Phase I Trial to Investigate Safety and Pharmacokinetics of Apetrol ES and Megace® under Fed Conditions in Healthy Male Volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Apetrol ES | sequences of administered drugs |
Timeline
- Start date
- 2011-03-01
- Primary completion
- 2011-05-01
- Completion
- 2011-08-01
- First posted
- 2011-04-26
- Last updated
- 2012-10-10
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01342055. Inclusion in this directory is not an endorsement.